Intravitreal injection of triamcinolone acetonide for immune recovery uveitis

Retina

Volumn 26, Issue 5, 2006, Pages 578-580

  Sirimaharaj, Maytinee ^a   Robinson, Michael R ^b   Zhu, Meidong ^a   Csaky, Karl G ^b   Donovan, Basil ^c,d   Sutter, Florian ^a   Gillies, Mark C ^a,c,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL EYE INSTITUTE   (United States)

^c SYDNEY EYE HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cystoid macular edema; Immune recovery uveitis; Intravitreal triamcinolone

Indexed keywords

FOSCARNET; GANCICLOVIR; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; ANTIVIRUS AGENT; GLUCOCORTICOID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RECOVERY UVEITIS; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA EDEMA; RETINITIS; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UVEITIS; VISION; VISUAL ACUITY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; IMMUNOLOGY; INJECTION; LEUKOCYTOSIS; RETINA MACULA CYSTOID EDEMA; VISUAL DISORDER; VITREOUS BODY;

ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS RETINITIS; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LEUKOCYTOSIS; MACULAR EDEMA, CYSTOID; MALE; TRIAMCINOLONE ACETONIDE; UVEITIS; VISION DISORDERS; VISUAL ACUITY; VITREOUS BODY;

EID: 33745785303     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200605000-00013     Document Type: Article

References (8)

1. Robinson MR, Reed G, Csaky KG. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 2000;130:49-56.
2. Karavellas MP, Azen SP, Macdonald JC. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina 2001;21:1-9.
3. Nguyen QD, Kempen JH, Bolton SG. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000;129:634-639.
4. Wright ME, Suzman DL, Csaky KG, Masur H, Polis MA, Robinson MR. Extensive retinal neovascularization as a late finding in HIV-infected patients with immune recovery uveitis. Clin Infect Dis 2003;36:1063-1066.
5. Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol 2000;130:240-241.
6. Hillebrand-Haverkort ME, Prummel MF, ten Veen JH. Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone. AIDS 1999;13:1803.
7. Clevenbergh P, Corcostegui M, Gerard D, et al. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. J Infect 2002;44:194-195.
8. Gillies MC, Luo W, Hunyor AB, et al. Safety of an intravitreal injection of triamcinolone acetonide: results from a randomised clinical trial. Arch Ophthalmol 2004;122:336-340.